Well, went in June for my better half's 3-month checkup. Everthing OK, bloods etc. Results of bone marrow biopsy really good. CLL down to 6% in the bone marrow. This is probably as low as it will go according to our Professor, but he is really pleased with that. All I can say is thank God for Dr Mendis at Medway Maritime Hospital referring us to Kings College for this trial. We know the CLL will never "go away", but it is under control with this drug.
Progress on ACP-196 Trial: Well, went in June... - CLL Support
Progress on ACP-196 Trial
Written by
babswade
To view profiles and participate in discussions please or .
Read more about...
3 Replies
•
Congratulations. Great news🍾🍷🙏🏻👍🏻💪💃
Brilliant news! 😬
Not what you're looking for?
You may also like...
ACP-196 (BTK inhibitor acalabrutinib) Trial
point on this trial. Bloods etc are all OK. He had a bone marrow biopsy while we were at Kings...
ACP-196 (Acalabrutinib) TRIAL - 31st monthly cycle achieved with full remission
outcome of this trial and can't thank Professor Devereux and his team at Kings College Hospital...
Have Johnson & Johnson and AstraZeneca done one better than AbbVie, purchasing 55 percent of Acerta Pharma for acalabrutinib (ACP-196)?
reported promising results from mid-phase trials of its drug last week, suggesting it may be even...
Progression Free Survival (PFS) post Discontinuation of Ibrutinib in E1912 Trial
mes-than-fcr-in-naive-cll-patients-results-from-the-ecog-acrin-phase-iii-trial-e1912 Main take home
recent immunotherapy trial results
remission (est 14 months). He has an other bone marrow biopsy scheduled mid- September and we will...